130 related articles for article (PubMed ID: 15634279)
1. Factor H binds to washed human platelets.
Vaziri-Sani F; Hellwage J; Zipfel PF; Sjöholm AG; Iancu R; Karpman D
J Thromb Haemost; 2005 Jan; 3(1):154-62. PubMed ID: 15634279
[TBL] [Abstract][Full Text] [Related]
2. Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.
Ståhl AL; Vaziri-Sani F; Heinen S; Kristoffersson AC; Gydell KH; Raafat R; Gutierrez A; Beringer O; Zipfel PF; Karpman D
Blood; 2008 Jun; 111(11):5307-15. PubMed ID: 18268093
[TBL] [Abstract][Full Text] [Related]
3. Factor H binds to platelet integrin alphaIIbbeta3.
Mnjoyan Z; Li J; Afshar-Kharghan V
Platelets; 2008 Nov; 19(7):512-9. PubMed ID: 18979363
[TBL] [Abstract][Full Text] [Related]
4. Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb/IIIa.
Horn M; Bertling A; Brodde MF; Müller A; Roth J; Van Aken H; Jurk K; Heilmann C; Peters G; Kehrel BE
J Thromb Haemost; 2012 Apr; 10(4):647-61. PubMed ID: 22268819
[TBL] [Abstract][Full Text] [Related]
5. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
6. Identification of a new class of inducible receptors on platelets. Thrombospondin interacts with platelets via a GPIIb-IIIa-independent mechanism.
Aiken ML; Ginsberg MH; Plow EF
J Clin Invest; 1986 Dec; 78(6):1713-6. PubMed ID: 3782477
[TBL] [Abstract][Full Text] [Related]
7. GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole blood.
Furman MI; Krueger LA; Frelinger AL; Barnard MR; Mascelli MA; Nakada MT; Michelson AD
Thromb Haemost; 2000 Sep; 84(3):492-8. PubMed ID: 11019977
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein IIb-IIIa-liposomes bind fibrinogen but do not undergo fibrinogen-mediated aggregation.
Sloan SM; Brown EB; Liu Q; Frojmovic MM
Platelets; 2000 Mar; 11(2):99-110. PubMed ID: 10938888
[TBL] [Abstract][Full Text] [Related]
9. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.
Jokiranta TS; Cheng ZZ; Seeberger H; Jòzsi M; Heinen S; Noris M; Remuzzi G; Ormsby R; Gordon DL; Meri S; Hellwage J; Zipfel PF
Am J Pathol; 2005 Oct; 167(4):1173-81. PubMed ID: 16192651
[TBL] [Abstract][Full Text] [Related]
10. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
11. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.
Mondoro TH; Wall CD; White MM; Jennings LK
Blood; 1996 Nov; 88(10):3824-30. PubMed ID: 8916946
[TBL] [Abstract][Full Text] [Related]
12. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.
Lehtinen MJ; Rops AL; Isenman DE; van der Vlag J; Jokiranta TS
J Biol Chem; 2009 Jun; 284(23):15650-8. PubMed ID: 19351878
[TBL] [Abstract][Full Text] [Related]
13. Factor H family proteins: on complement, microbes and human diseases.
Zipfel PF; Skerka C; Hellwage J; Jokiranta ST; Meri S; Brade V; Kraiczy P; Noris M; Remuzzi G
Biochem Soc Trans; 2002 Nov; 30(Pt 6):971-8. PubMed ID: 12440956
[TBL] [Abstract][Full Text] [Related]
14. Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa.
Cox AD; Devine DV
Blood; 1994 Feb; 83(4):1006-16. PubMed ID: 7906563
[TBL] [Abstract][Full Text] [Related]
15. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.
Ruiz C; Liu CY; Sun QH; Sigaud-Fiks M; Fressinaud E; Muller JY; Nurden P; Nurden AT; Newman PJ; Valentin N
Blood; 2001 Oct; 98(8):2432-41. PubMed ID: 11588040
[TBL] [Abstract][Full Text] [Related]
16. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
Hyvärinen S; Meri S; Jokiranta TS
Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
[TBL] [Abstract][Full Text] [Related]
17. Platelet-fibrinogen interactions.
Bennett JS
Ann N Y Acad Sci; 2001; 936():340-54. PubMed ID: 11460491
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein specifically binds glycoprotein IIb/IIIa: a flow cytometric method for ligand-receptor interaction.
Tetik S; Uras F; Ekşioğlu-Demiralp E; Turay Yardimci K
Clin Appl Thromb Hemost; 2008 Apr; 14(2):210-9. PubMed ID: 18160616
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
Shido K; Ahmad G; Hsu L; Kamiyama M
J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
[TBL] [Abstract][Full Text] [Related]
20. Platelet integrin alpha IIb beta 3 (GPIIb-IIIa) is not implicated in the binding of LDL to intact resting platelets.
Pedreño J; Fernández R; Cullaré C; Barceló A; Elorza MA; de Castellarnau C
Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):156-63. PubMed ID: 9012651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
